Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health total assets
Total assets on the balance sheet at the end of each period.
Aspira Women's Health's total assets was $4.44M at Jun 30, 2026. For fiscal 2025 it was $5.46M, down 0.6% from the year before. Over ten years it grew -12.6% a year on average. The highest annual figure on record is $41.08M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.46M | -0.6% |
| FY2024 | Dec 31, 2024 | $5.49M | -12.3% |
| FY2023 | Dec 31, 2023 | $6.26M | -64.0% |
| FY2022 | Dec 31, 2022 | $17.37M | -57.7% |
| FY2021 | Dec 31, 2021 | $41.08M | +109.5% |
| FY2020 | Dec 31, 2020 | $19.61M | +41.8% |
| FY2019 | Dec 31, 2019 | $13.83M | +21.2% |
| FY2018 | Dec 31, 2018 | $11.41M | +52.2% |
| FY2017 | Dec 31, 2017 | $7.50M | -6.5% |
| FY2016 | Dec 31, 2016 | $8.02M | -61.7% |
| FY2015 | Dec 31, 2015 | $20.96M | -13.3% |
| FY2014 | Dec 31, 2014 | $24.17M | -21.1% |
| FY2013 | Dec 31, 2013 | $30.64M | +254.9% |
| FY2012 | Dec 31, 2012 | $8.63M | -62.6% |
| FY2011 | Dec 31, 2011 | $23.11M | -3.8% |
| FY2010 | Dec 31, 2010 | $24.04M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.44M | -10.1% |
| Q1 FY2026 | Mar 31, 2026 | $5.09M | -24.2% |
| Q4 FY2025 | Dec 31, 2025 | $5.46M | -0.6% |
| Q3 FY2025 | Sep 30, 2025 | $7.30M | +53.3% |
| Q2 FY2025 | Jun 30, 2025 | $4.93M | -10.1% |
| Q1 FY2025 | Mar 31, 2025 | $6.72M | -6.3% |
| Q4 FY2024 | Dec 31, 2024 | $5.49M | -12.3% |
| Q3 FY2024 | Sep 30, 2024 | $4.76M | -45.1% |
| Q2 FY2024 | Jun 30, 2024 | $5.49M | -28.9% |
| Q1 FY2024 | Mar 31, 2024 | $7.16M | -37.7% |
| Q4 FY2023 | Dec 31, 2023 | $6.26M | -64.0% |
| Q3 FY2023 | Sep 30, 2023 | $8.66M | -63.8% |
| Q2 FY2023 | Jun 30, 2023 | $7.72M | -67.9% |
| Q1 FY2023 | Mar 31, 2023 | $11.50M | -62.7% |
| Q4 FY2022 | Dec 31, 2022 | $17.37M | -57.7% |
| Q3 FY2022 | Sep 30, 2022 | $23.94M | -50.2% |
| Q2 FY2022 | Jun 30, 2022 | $24.02M | -57.0% |
| Q1 FY2022 | Mar 31, 2022 | $30.86M | -50.5% |
| Q4 FY2021 | Dec 31, 2021 | $41.08M | +109.5% |
| Q3 FY2021 | Sep 30, 2021 | $48.05M | +125.9% |
| Q2 FY2021 | Jun 30, 2021 | $55.83M | +326.5% |
| Q1 FY2021 | Mar 31, 2021 | $62.30M | +501.7% |
| Q4 FY2020 | Dec 31, 2020 | $19.61M | +41.8% |
| Q3 FY2020 | Sep 30, 2020 | $21.27M | +28.6% |
| Q2 FY2020 | Jun 30, 2020 | $13.09M | -27.9% |
| Q1 FY2020 | Mar 31, 2020 | $10.35M | +25.4% |
| Q4 FY2019 | Dec 31, 2019 | $13.83M | +21.2% |
| Q3 FY2019 | Sep 30, 2019 | $16.53M | +22.7% |
| Q2 FY2019 | Jun 30, 2019 | $18.15M | +12.6% |
| Q1 FY2019 | Mar 31, 2019 | $8.25M | +51.5% |
| Q4 FY2018 | Dec 31, 2018 | $11.41M | +52.2% |
| Q3 FY2018 | Sep 30, 2018 | $13.47M | +39.2% |
| Q2 FY2018 | Jun 30, 2018 | $16.12M | +97.2% |
| Q1 FY2018 | Mar 31, 2018 | $5.45M | -47.8% |
| Q4 FY2017 | Dec 31, 2017 | $7.50M | -6.5% |
| Q3 FY2017 | Sep 30, 2017 | $9.68M | -9.4% |
| Q2 FY2017 | Jun 30, 2017 | $8.17M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.44M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.02M | – |
| Q3 FY2016 | Sep 30, 2016 | $10.68M | – |
See a number that looks wrong?